
    
      Adult patients with either type 1 or type 2 diabetes will be enrolled with baseline
      measurement of visual acuity, contrast sensitivity, color vision, threshold macular
      perimetry, macular pigment optical density, optical coherence tomography, glycosylated
      hemoglobin, blood lipids and serum vitamin D status. A multi-component dietary supplement
      containing ingredients currently available over the counter in the US will be taken for six
      months and repeat measurements of the above parameters obtained.
    
  